Zenas Biopharma Shares Surge 5.5% to $28.41 Amid Positive Peer Momentum and FDA Approval Buzz
Explore why Zenas Biopharma shares rose 5.5% to $28.41, its $1.7B market cap, and what peers like Agios and Vera Therapeutics are doing this week.
- ZENAS BIOPHARMA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read


